DC Chemicals

All products / DC11448

LOXO 195(Selitrectinib)
CAT. NO. DC11448

LOXO 195(Selitrectinib)

Pack sizes and prices

Pack sizePrice
100 mg$750 USDRequest a quote →
250 mg$1,400 USDRequest a quote →
1 g$2,800 USDRequest a quote →

In stock. Contact our team for lead time, shipping and final quotation.

Product overview

LOXO-195 is a next-generation TRK kinase inhibitor (TKI), with IC50s of 0.6 nM, <2.5 nM for TRKA and TRKC respectively.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC11448
Product nameLOXO 195(Selitrectinib)
CAS2097002-61-2
Molecular formulaC20H21FN6O
Molecular weight380.4187
Purity>98%
SMILESFC1C([H])=NC2C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])N([H])C(C3C([H])=NN4C([H])=C([H])C(=NC4=3)N3C([H])([H])C([H])([H])C([H])([H])[C@]3([H])C=2C=1[H])=O

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — LOXO 195(Selitrectinib) (DC11448)

Source references

[1]. Drilon A, et al. A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion-Positive Solid Tumors. Cancer Discov. 2017 Sep;7(9):963-972.

Related research products